Protecting Public Health: Proposed Guidelines for Pharmaceutical Product Distribution

▴ Proposed Guidelines for Pharmaceutical Product Distribution
It is essential for all involved parties to adhere to these guidelines to prevent the introduction of sub-standard products into the market and uphold the highest standards of quality assurance in pharmaceutical distribution.

The Central Drugs Standard Control Organisation (CDSCO) has released draft guidelines aimed at implementing good distribution practices within the pharmaceutical industry to prevent the circulation of spurious, adulterated, and sub-standard products in the market. These guidelines align with the WHO Technical Report Series (TRS) on good storage and distribution practices for pharmaceuticals.

The objective of these guidelines is to establish and maintain a robust quality system throughout the distribution process, from the manufacturer's premises to the end recipient, ensuring the safety and efficacy of pharmaceutical products.

Key Highlights of the Draft Guidelines:

Establishment of Quality System: Pharmaceutical product distributors are mandated to establish and maintain a comprehensive quality system. Each distribution site must appoint a responsible person designated by management to oversee the implementation and maintenance of the quality system.

Documented Procedures and Deviations: The guidelines emphasize the documentation of established procedures and the investigation of any deviations encountered during distribution. Deviations must be appropriately documented and investigated, with corrective and preventive actions (CAPA) implemented to rectify deviations and prevent their recurrence.

Product Recall Procedures: In cases where product recall is necessary, the guidelines stipulate that recalled products must be segregated during transit and clearly labeled as such. If segregation is not feasible during transit, recalled goods should be securely packaged, labeled, and accompanied by appropriate documentation.

Prompt Communication on Product Recall: All customers and competent authorities in countries where the product has been distributed must be promptly informed of any intention to recall a pharmaceutical product.

Disposal of Returned Products: Returned products should be destroyed in accordance with international, national, and local requirements, considering environmental protection. Returned products can only be retained if their quality is confirmed to be satisfactory through a documented and authorized procedure.

Dispatch Records and Traceability: Detailed records of product dispatches must include essential information such as product description, dosage form, strength, quantity, batch number, and expiry date. These records should enable the traceability of pharmaceutical products throughout the distribution process.

The draft guidelines showcases the critical importance of maintaining high standards in pharmaceutical distribution to safeguard public health and safety. By implementing these guidelines effectively, stakeholders across the supply chain can contribute to ensuring the integrity and quality of pharmaceutical products reaching patients and healthcare providers.

It is essential for all involved parties to adhere to these guidelines to prevent the introduction of sub-standard products into the market and uphold the highest standards of quality assurance in pharmaceutical distribution. These measures are imperative in safeguarding public health and maintaining consumer confidence in the pharmaceutical industry.

Tags : #

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026